Literature DB >> 17107724

Influence of epicardial adipose tissue and adipocytokine levels on cardiac abnormalities in visceral obesity.

Alexis E Malavazos, Federica Ermetici, Calin Coman, Massimiliano M Corsi, Lelio Morricone, Bruno Ambrosi.   

Abstract

Adipocytokine levels and visceral adipose tissue (VAT) seem to be associated with some cardiac abnormalities and a role of visceral fat in predisposing to cardiac dysfunction, possibly through a low-grade state of inflammation, has been demonstrated. In this study we firstly show that elevated levels of both monocyte chemoattractant protein 1 (MCP-1) and soluble IL-6 receptor/interleukin-6 (sIL-6R/IL-6) complex are closely correlated with epicardial fat thickness.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17107724     DOI： 10.1016/j.ijcard.2006.08.061

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  29 in total

Review 1.  Do cardiac and perivascular adipose tissue play a role in atherosclerosis?

Authors:  Gianluca Iacobellis; Yu-Jing Gao; Arya M Sharma
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

2.  Evaluation of therelationship between epicardial adipose tissue and myocardial performance (Tei) index.

Authors:  Sahin Kaplan; Mustafa Oztürk; Gülhanım Kırış; Safiye Tuba Kaplan
Journal:  Int J Clin Exp Med       Date:  2014-06-15

3.  Impaired coronary microvascular endothelial function in men with metabolic syndrome.

Authors:  Hiroki Teragawa; Naoya Mitsuba; Kenji Nishioka; Kentaro Ueda; Shingo Kono; Yukihito Higashi; Kazuaki Chayama; Yasuki Kihara
Journal:  World J Cardiol       Date:  2010-07-26

4.  Epicardial adipose tissue thickness in type 1 diabetic patients.

Authors:  Dilek Yazıcı; Beste Özben; Dilek Yavuz; Oğuzhan Deyneli; Hasan Aydın; Özlem Tarcin; Sema Akalın
Journal:  Endocrine       Date:  2011-05-08       Impact factor: 3.633

Review 5.  Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Authors:  Annamaria Mascolo; Konrad Urbanek; Antonella De Angelis; Maurizio Sessa; Cristina Scavone; Liberato Berrino; Giuseppe Massimo Claudio Rosano; Annalisa Capuano; Francesco Rossi
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

6.  Obesity and preclinical changes of cardiac geometry and function.

Authors:  Joong Kyung Sung; Jang-Young Kim
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

7.  Association of serum hepatocyte growth factor with pericardial fat volume in patients with coronary artery disease.

Authors:  Jingning Liu; Zhengxia Liu; Shikun Cai; Peng Lu; Xiang Lu; Gang Peng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  The relationship of ectopic lipid accumulation to cardiac and vascular function in obesity and metabolic syndrome.

Authors:  Frederick L Ruberg; Zhongjing Chen; Ning Hua; Sherman Bigornia; Zifang Guo; Kevin Hallock; Hernan Jara; Michael LaValley; Alkystis Phinikaridou; Ye Qiao; Jason Viereck; Caroline M Apovian; James A Hamilton
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

9.  Improvement in cardiovascular indices after Roux-en-Y gastric bypass or sleeve gastrectomy for morbid obesity.

Authors:  Alexander Kokkinos; Kleopatra Alexiadou; Christos Liaskos; Georgia Argyrakopoulou; Ioanna Balla; Nicholas Tentolouris; Ioannis Moyssakis; Nicholas Katsilambros; Irene Vafiadis; Andreas Alexandrou; Theodoros Diamantis
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

10.  Pseudo cardiac tamponade in the setting of excess pericardial fat.

Authors:  Thang Nguyen; Kanwal Kumar; Andrew Francis; Jonathan R Walker; Michael Raabe; Shelley Zieroth; Davinder S Jassal
Journal:  Cardiovasc Ultrasound       Date:  2009-01-22       Impact factor: 2.062
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.